MX2015015784A - Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino. - Google Patents

Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino.

Info

Publication number
MX2015015784A
MX2015015784A MX2015015784A MX2015015784A MX2015015784A MX 2015015784 A MX2015015784 A MX 2015015784A MX 2015015784 A MX2015015784 A MX 2015015784A MX 2015015784 A MX2015015784 A MX 2015015784A MX 2015015784 A MX2015015784 A MX 2015015784A
Authority
MX
Mexico
Prior art keywords
methods
inflammatory bowel
disease
diagnosing
bowel disease
Prior art date
Application number
MX2015015784A
Other languages
English (en)
Inventor
A Hackney Jason
Mary Keir
Lilyan Yi Tian Wright
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2015015784A publication Critical patent/MX2015015784A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan biomarcadores para diagnosticar enfermedad inflamatoria de intestino, incluyendo enfermedad de Crohn, incluyendo enfermedad fibrótica o fibroestenótica de Crohn, y colitis ulcerativa y métodos para usar estos biomarcadores. Además, se proporcionan métodos para tratar trastornos inflamatorios gastrointestinales tal como enfermedades inflamatorias de intestino incluyendo colitis ulcerativa y enfermedad de Crohn, incluyendo enfermedad fibrótica o fibroestenótica de Crohn.
MX2015015784A 2013-05-17 2014-05-16 Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino. MX2015015784A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361824661P 2013-05-17 2013-05-17
PCT/US2014/038434 WO2014186728A2 (en) 2013-05-17 2014-05-16 Methods for diagnosing and treating inflammatory bowel disease

Publications (1)

Publication Number Publication Date
MX2015015784A true MX2015015784A (es) 2016-03-11

Family

ID=51899021

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015015784A MX2015015784A (es) 2013-05-17 2014-05-16 Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino.

Country Status (11)

Country Link
US (1) US20160178644A1 (es)
EP (1) EP2997162A4 (es)
JP (1) JP2016521540A (es)
KR (1) KR20160005044A (es)
CN (1) CN105209643A (es)
BR (1) BR112015028338A2 (es)
CA (1) CA2910199A1 (es)
HK (1) HK1219512A1 (es)
MX (1) MX2015015784A (es)
RU (1) RU2015149032A (es)
WO (1) WO2014186728A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017009695A (es) 2015-01-29 2018-04-10 Univ Oxford Innovation Ltd Objetivo terapeutico y biomarcador en enfermedad inflamatoria intestinal (ibd).
GB201616557D0 (en) * 2016-09-29 2016-11-16 Secretary Of State For Health The Assay for distinguishing between sepsis and systemic inflammatory response syndrome
US10811126B2 (en) * 2016-12-14 2020-10-20 Tracy Warren System and methods for developing and using a microbiome-based action component for patient health
US11978543B2 (en) 2016-12-14 2024-05-07 Astarte Medical Partners Inc. System and methods for developing and using a microbiome-based action component
BR112019013463A2 (pt) * 2016-12-29 2020-01-07 University Of Miami Método para a modulação da atividade de inflamassoma e da inflamação nos pulmões
US11840565B2 (en) 2016-12-29 2023-12-12 University Of Miami Methods and compositions for treating virus-associated inflammation
EP3654993A4 (en) * 2017-07-17 2021-08-25 The Broad Institute, Inc. HUMAN COLON CELL ATLAS IN GOOD HEALTH WITH HEMORRHAGIC RECTO-COLITIS
GB201717301D0 (en) * 2017-10-20 2017-12-06 Nordic Bioscience As Type xvi collagen assay
EP3752643B1 (en) * 2018-02-12 2024-01-17 F. Hoffmann-La Roche AG Method of predicting response to therapy by assessing tumor genetic heterogeneity
CA3121167A1 (en) * 2018-11-29 2020-06-04 Cedars-Sinai Medical Center Methods of stratifying and treating a sub-population of inflammatory bowel disease patients
WO2020241778A1 (ja) * 2019-05-29 2020-12-03 国立大学法人九州大学 線維化を抑制する医薬組成物
KR102577697B1 (ko) * 2019-11-13 2023-09-14 주식회사 나이벡 염증 및 상처 치료용 펩타이드
WO2021247548A1 (en) * 2020-06-03 2021-12-09 Cedars-Sinai Medical Center Treatments for a sub-population of inflammatory bowel disease patients
WO2022140667A2 (en) * 2020-12-23 2022-06-30 Icahn School Of Medicine At Mount Sinai Method for treating crohn's disease
WO2023286694A1 (ja) 2021-07-13 2023-01-19 国立大学法人東海国立大学機構 炎症性腸疾患を治療するための医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1667669A2 (en) * 2003-05-30 2006-06-14 Molecular Staging, Inc. Inflammatory bowel diseases
WO2010042903A1 (en) * 2008-10-09 2010-04-15 Alfagene Bioscience, Inc Use and identification of biomarkers for gastrointestinal diseases
AU2010236568B2 (en) * 2009-04-14 2015-08-27 Société des Produits Nestlé S.A. Inflammatory bowel disease prognostics
EP2456890A1 (en) * 2009-07-20 2012-05-30 Genentech, Inc. Gene expression markers for crohn's disease
JP2013537539A (ja) * 2010-08-13 2013-10-03 ジェネンテック， インコーポレイテッド 疾患の治療のためのＩＬ−１β及びＩＬ−１８に対する抗体

Also Published As

Publication number Publication date
CA2910199A1 (en) 2014-11-20
WO2014186728A2 (en) 2014-11-20
KR20160005044A (ko) 2016-01-13
RU2015149032A (ru) 2017-06-22
JP2016521540A (ja) 2016-07-25
EP2997162A4 (en) 2017-02-01
EP2997162A2 (en) 2016-03-23
CN105209643A (zh) 2015-12-30
BR112015028338A2 (pt) 2017-07-25
US20160178644A1 (en) 2016-06-23
WO2014186728A3 (en) 2015-01-22
HK1219512A1 (zh) 2017-04-07

Similar Documents

Publication Publication Date Title
MX2015015784A (es) Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino.
MX2022010809A (es) Antagonistas de integrina-beta7 para usarse en el tratamiento y diagnostico de trastornos inflamatorios gastrointestinales.
CA2941917C (en) Methods for the diagnosis and treatment of inflammatory bowel disease
IL252796B (en) Therapeutic, diagnostic and prognostic methods for bladder cancer
IL269529A (en) Methods for diagnosing and treating inflammatory bowel disease
EP3131931A4 (en) Methods for increasing red blood cell levels and treating sickle-cell disease
IL246917A0 (en) Biomarker and early diagnosis methods for Alzheimer's disease
MX2016002879A (es) Sistemas, dispositivos y metodos para la terapia anti-tl1a.
MX2019006948A (es) Probioticos para su uso en el tratamiento de diverticulosis y enfermed diverticular.
EP3186397C0 (en) USE OF BIOMARKERS OF CIRCULATING CELLS IN THE BLOOD FOR THE DETECTION AND DIAGNOSIS OF DISEASES, AND THEIR ISOLATION PROCESSES
WO2016106343A8 (en) Probiotic organisms for diagnosis, monitoring, and treatment of inflammatory bowel disease
EA201890747A1 (ru) Способы лечения воспалительных заболеваний
WO2014197835A3 (en) Methods and compositions for the treatment of cancer
NZ738100A (en) Igfbp3 and uses thereof
WO2014205266A3 (en) Compositions and methods for detecting and treating glioblastoma
HK1214752A1 (zh) 由產甲烷菌引起或與之相關的疾病及病狀的診斷、選擇及治療方法
EP3024482A4 (en) Methods for diagnosing and treating immune disease
MA40592A (fr) Compositions et méthodes pour le traitement d'une maladie inflammatoire de l'intestin à l'aide d'une polythérapie à base d'inhibiteurs à petites molécules de récepteur 9 de chimiokine c-c (ccr9) et d'anticorps bloquants anti-intégrine alpha4beta7
HK1207420A1 (en) Diagnosis and treatment of motility disorders of the gut and bladder, and of fibromyalgia
EP3602041A4 (en) METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY INTESTINE DISEASE
EP2983693A4 (en) SEPT4 / ARTS AS A TUMOR SUPPRESSOR IN THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF HEPATIC DISORDERS
WO2015013233A3 (en) Methods and compositions for the treatment and diagnosis of bladder cancer
WO2017019673A3 (en) Methods for diagnosing and treating inflammatory bowel disease
WO2013119990A3 (en) Detection and treatment of cd30+ cancers
SG194235A1 (en) Methods of predicting the development of complement-mediated disease